Genotyping of Circulating Tumor DNA in Cholangiocarcinoma Reveals Diagnostic and Prognostic Information

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-49860-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeted Genotyping of Circulating Tumor Dna for Classical Hodgkin Lymphoma Monitoring: A Prospective Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Genotyping Primary Mediastinal B-Cell Lymphoma (Pmbcl) by Means of Circulating Tumor Dna Analysis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Targeted Genotyping of Circulating Tumor DNA for Classical Hodgkin Lymphoma Monitoring: A Prospective Study

Haematologica
Hematology
2020English

Serum miR-26a as a Diagnostic and Prognostic Biomarker in Cholangiocarcinoma

Oncotarget
Oncology
2015English

The Circulating miRNAs as Diagnostic and Prognostic Markers

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
2019English

Reply To: “Diagnostic and Prognostic Role of Circulating Microparticles in Hepatocellular Carcinoma”

Journal of Hepatology
Hepatology
2018English

Diagnostic Value of Circulating Tumor DNA as an Effective Biomarker in Cervical Cancer: A Meta-Analysis

2019English

Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

Scientific Reports
Multidisciplinary
2016English

Circulating Cell-Free DNA for Metastatic Cervical Cancer Detection, Genotyping and Monitoring

Clinical Cancer Research
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy